Covance adding mass spec for biosimilars
Covance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services.
View ArticleParexel discusses transdermal drug delivery techs
Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.
View ArticleAn experienced CMO is key to successful biologics development says Cobra...
Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.
View ArticleUnilife launches Autoinfuser range publically
Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.
View ArticleAcuros in talks with Big Pharma over water-powered delivery pump
Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.
View ArticleEuropean CMO market will double in just 6 years, says Frost & Sullivan
The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.
View ArticleEMD Millipore stresses ease of use and flexibility benefits of new bioreactor
EMD Millipore premiered a new single-use bioreactor at Interphex 2012, claiming the new design addresses industry demand for ease of use and flexibility.
View ArticleThe single-use age has dawned, says ThermoFisher
Developments in single-use technology signals the end for clean-in-place biomanufacturing methods, according to ThermoFisher’s Bill Whitford.
View ArticleATMI gears up for single-use "boom" for biotech industry
ATMI has added helium integrity testing of bioprocess vessels in response to what it says is a boom in the single-use technology arena.
View ArticleATMI: Single Use Bioreactors on the Up, but US Tails Europe
New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.
View ArticleTech and Regulatory Issues? Biotech/Manufacturing Firms Discuss
Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the issues affecting the biotech industry today, according to experts at this year’s Interphex.
View ArticleCustomers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.
View ArticleThermo Fisher: Single-Use Tech's Evolution and Increased Industry Use
Over the last decade single-use technologies have moved into manufacturing scales and are increasingly being deployed worldwide, according to Thermo Fisher Scientific.
View ArticleImmunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
View ArticleBetter single-use cross flow techs still needed says GE Healthcare
The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.
View Article'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words.
View ArticleStart spreading the news, Interphex opens today
When Frank Sinatra sang "If you can make it there, you can make it anywhere" in New York, New York he probably wasn't talking about biopharmaceutical production.
View ArticleTo QbD or not to QbD? For biologics it's a must says Cook Pharmica expert
The thorny issue of applying QbD to biopharmaceutical manufacture is a topic of hot debate at Interphex 2014 according to CMO Cook Pharmica.
View ArticleSo far, so very good: Pall and ATMI talk integration at interphex
While there will always be space for stainless steel systems, single-use technology is now mainstream according to Pall and ATMI.
View ArticleCatalent commits to ADCs by upping its stake in Redwood
Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.
View Article
